These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19875196)

  • 1. [Administration of statins during the acute phase of acute coronary syndrome].
    Ruiz-Bailén M
    Med Intensiva; 2010; 34(1):56-63. PubMed ID: 19875196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very early initiation of statin therapy and mortality in patients with acute coronary syndrome.
    Angeli F; Reboldi G; Garofoli M; Ramundo E; Verdecchia P
    Acute Card Care; 2012 Mar; 14(1):34-9. PubMed ID: 22295883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes.
    Thadani U
    Am J Cardiovasc Drugs; 2009; 9(3):211-2; author reply 212. PubMed ID: 19463025
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early treatment of statins after acute coronary syndrome?].
    Hamm CW
    Dtsch Med Wochenschr; 2011 Sep; 136(39):1941. PubMed ID: 21948603
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early administrations of statins after acute coronary syndrome].
    Linde JJ; Jensen GB
    Ugeskr Laeger; 2012 Jun; 174(26):1801-3. PubMed ID: 22735112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins in acute coronary syndrome: very early initiation and benefits.
    Angeli F; Reboldi G; Mazzotta G; Garofoli M; Cerasa MF; Verdecchia P
    Ther Adv Cardiovasc Dis; 2012 Aug; 6(4):163-74. PubMed ID: 22789992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statins in acute coronary syndrome].
    Lama T A; Vega A J
    Rev Med Chil; 2008 Aug; 136(8):1083-5. PubMed ID: 18949196
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationships between chronic use of statin therapy, presentation of acute coronary syndromes and one-year mortality after an incident acute coronary event.
    Vervueren PL; Elbaz M; Dallongeville J; Arveiler D; Ruidavets JB; Montaye M; Wagner A; Amouyel P; Haas B; Bongard V; Ferrières J
    Int J Cardiol; 2013 Feb; 163(1):102-4. PubMed ID: 22790192
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG).
    Javed U; Deedwania PC; Bhatt DL; Cannon CP; Dai D; Hernandez AF; Peterson ED; Fonarow GC
    Am Heart J; 2010 Dec; 160(6):1130-6, 1136.e1-3. PubMed ID: 21146668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience).
    Elbarouni B; Banihashemi SB; Yan RT; Welsh RC; Kornder JM; Wong GC; Anderson FA; Spencer FA; Grondin FR; Goodman SG; Yan AT;
    Am J Cardiol; 2012 May; 109(10):1418-24. PubMed ID: 22381155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Celik M; Celik T
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663
    [No Abstract]   [Full Text] [Related]  

  • 13. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
    Marenzi G; Cosentino N; Werba JP; Tedesco CC; Veglia F; Bartorelli AL
    Int J Cardiol; 2015 Mar; 183():47-53. PubMed ID: 25662053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the efficacy of statin treatment in acute coronary syndromes.
    Rosa GM; Carbone F; Parodi A; Massimelli EA; Brunelli C; Mach F; Vuilleumier N; Montecucco F
    Eur J Clin Invest; 2014 May; 44(5):501-15. PubMed ID: 24601937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statins in the management of acute coronary syndrome].
    Matoba T; Egashira K
    Nihon Rinsho; 2010 Apr; 68(4):692-8. PubMed ID: 20387563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic aspirin and statin therapy in patients with impaired renal function and acute coronary syndromes: results from the IN-ACS Outcome Registry.
    Sciahbasi A; Rizzello V; Gonzini L; Giampaoli S; Greco C; Di Pasquale G; Mureddu GF; Di Chiara A; Lioy E; Boccanelli A
    Eur J Prev Cardiol; 2014 Feb; 21(2):214-21. PubMed ID: 22952286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy.
    De Luca G; Navarese EP; Cassetti E; Verdoia M; Suryapranata H
    Am J Cardiol; 2011 Jan; 107(2):198-203. PubMed ID: 21211597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.
    Kumar A; Cannon CP
    J Interv Cardiol; 2007 Dec; 20(6):447-57. PubMed ID: 18042049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of early high dose statins in acute coronary syndrome.
    Dougherty PJ; Arora RR
    Am J Ther; 2012 Sep; 19(5):369-76. PubMed ID: 22964560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of statins in patients with acute coronary syndromes].
    Urbinati S; Labanti G; Gambetti S
    G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 3):22S-26S. PubMed ID: 21491736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.